Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101293889B details a novel glycosylation method for artemisinin. Enhance solubility and reduce toxicity with our scalable pharmaceutical intermediate manufacturing.
Patent CN105753768B details a green two-step synthesis of nitrogen heterocycles from lactones, offering cost reduction and scalable manufacturing for pharma intermediates.
Patent CN106905350B reveals magnetic ionic liquid catalysis for thiazolo-pyridine derivatives, offering enhanced purity and scalable supply chain solutions.
Patent CN108285908B reveals a green enzymatic route for (S)-1-(2,6-dichloro-3-fluoro-phenyl) ethanol, offering superior purity and cost efficiency for API manufacturing.
Patent CN101104861B reveals a novel Yarrowia lipolytica lipase method for S-ibuprofen. Discover cost-effective, high-selectivity biocatalysis for pharmaceutical manufacturing.
Patent CN109721545A reveals high-yield synthesis for agrochemical intermediates. Discover cost reduction in agrochemical manufacturing and supply chain reliability.
Patent CN112480020A details a green visible light method for synthesizing benzoxazoles. This report analyzes cost reduction and supply chain reliability for pharma intermediates.
Novel organocatalysts for asymmetric epoxidation offering high enantioselectivity without transition metals, ensuring reliable supply chain stability.
Advanced patent analysis reveals efficient methyl furoate production using nano-gold catalysts. Significant cost reduction and supply chain reliability for fine chemical intermediates manufacturing.
Patent CN111560044B reveals a novel synthesis for 11-O-mogrol oxime ethers. Discover enhanced solubility, antioxidant activity, and scalable manufacturing for functional additives.
Patent CN116731988B reveals high-purity pharmaceutical intermediates synthesis via engineered ketoreductase, ensuring supply chain reliability and cost reduction.
Patent CN102174422B reveals high-activity lipase for chiral resolution. Offers solvent stability and cost reduction in biocatalysis manufacturing for pharma intermediates.
Patent CN115404249A reveals a novel enzymatic route for (S)-nicotine intermediates. Discover cost-effective biocatalysis solutions for scalable pharmaceutical manufacturing.
Novel synthesis method for 1 2-di-o-amino phenoxyl ethane ensures high purity and yield. Offers significant cost reduction and supply chain reliability for dye manufacturers.
Patent CN112010910B details a novel iridium-catalyzed synthesis of chiral ferrocene homoallylamines, offering high yields and enantioselectivity for cost-effective pharmaceutical intermediate manufacturing.
Patent CN106432103A reveals Au/TiO2 catalyzed quinazolinone synthesis. Offers high yield, recyclable catalyst, and scalable process for reliable pharmaceutical intermediates supplier partnerships.
Patent CN101535467B discloses a novel biocatalytic route for chiral hydroxy acids using Fusarium proliferatum ECU2002, offering high optical purity and scalable manufacturing solutions.
Patent CN1257468A reveals novel Cp*-metal catalysts for efficient asymmetric transfer hydrogenation, offering significant cost reduction in pharmaceutical manufacturing and safer processing.
Novel aminotransferase mutant enables 99% ee sitagliptin intermediate. Robust DMSO tolerance ensures cost reduction in pharma manufacturing.
Patent CN119912363A reveals a metal-free photoredox method for alpha-aryl cyclic ketones. This breakthrough offers significant cost reduction and supply chain reliability for fine chemical manufacturing.